Support and Funding
We are a non-profit, academic research program. The largest portion of our funding comes from National Institutes of Health (NIH) grants. These grants mainly support our observational research programs, including Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL), Longitudinal Evaluation of Familial Frontotemporal Dementia (LEFFTDS), and the Four Repeat Tauopathy Neuroimaging Initiative (4RTNI). We also receive NIH funds to support clinical trial preparations through the Alzheimer’s Clinical Trial Consortium (ACTC).
We are very grateful for support from philanthropic organizations and private foundations including the Association for Frontotemporal Degeneration (AFTD), the Bluefield Project to Cure Frontotemporal Dementia and the Tau Consortium. We have also been fortunate to receive support for our clinical trials through the UCSF Parkinson’s Spectrum Disorders Center. Additionally, we are proud to receive support through the University of California Cures Alzheimer’s Disease program.
A number of our clinical trials are sponsored by pharmaceutical or biotechnology companies. When the clinical trial has been designed and organized by a pharmaceutical company, UCSF receives funding from that company to support our work to conduct the clinical trial. Our investigators do not receive direct payments or incentives for conducting the trial. For some trials, we receive a donation of drug or other services from a pharmaceutical company, but the remainder of the study is funded by a foundation grant, the NIH, or a private donation.
Donations to our program are very much appreciated. We use these funds to help support trainees and staff, create new services, and in some cases, design and conduct new research programs.